CDLX Cardlytics
- 3.670
- +0.070+1.94%
Cardlytics News
Express News | Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Cardlytics, Inc. (CDLX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
Northland Securities Downgrades Cardlytics(CDLX.US) to Hold Rating, Cuts Target Price to $5
Express News | Cardlytics Inc : Northland Capital Cuts to Market Perform
Northland Securities Downgrades Cardlytics (CDLX) to a Hold
BofA Securities Downgrades Cardlytics(CDLX.US) to Sell Rating
Express News | Cardlytics Inc : BofA Global Research Cuts to Underperform From Neutral; Cuts Price Objective to $3.5 From $4
Bank of America Securities Remains a Sell on Cardlytics (CDLX)
Express News | B of A Securities Downgrades Cardlytics to Underperform, Lowers Price Target to $3.5
Craig-Hallum Downgrades Cardlytics(CDLX.US) to Hold Rating
Craig-Hallum Sticks to Its Hold Rating for Cardlytics (CDLX)
Director Scott Hill Acquires 40,000 Shares of Cardlytics Inc (CDLX)
Analysts Have Been Trimming Their Cardlytics, Inc. (NASDAQ:CDLX) Price Target After Its Latest Report
Cardlytics Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Top Midday Decliners
Express News | Northland Capital Markets Maintains Outperform on Cardlytics, Lowers Price Target to $7
Express News | Cardlytics Shares Are Trading Lower After the Company Reported Worse-than-expected Q2 Financial Results and Issued Q3 Revenue Guidance Below Estimates
Dow Jumps Over 500 Points; Eli Lilly Posts Upbeat Earnings
Cardlytics (CDLX) Was Downgraded to a Hold Rating at Needham
Hold Rating on Cardlytics Amid Operational Changes and CEO Transition
Analysis
Price Target
No Data
No Data